Article Versions Notes

Barrett A, Quinn J, Lavin M, Thornton P, O’Donnell J, Murphy P, Glavey S. Validation of Risk-Adapted Venous Thromboembolism Prediction in Multiple Myeloma Patients. Journal of Clinical Medicine. 2021; 10(16):3536. https://doi.org/10.3390/jcm10163536

Barrett, Aisling, John Quinn, Michelle Lavin, Patrick Thornton, James O’Donnell, Philip Murphy, and Siobhán Glavey. 2021. "Validation of Risk-Adapted Venous Thromboembolism Prediction in Multiple Myeloma Patients" Journal of Clinical Medicine 10, no. 16: 3536. https://doi.org/10.3390/jcm10163536

Barrett, A., Quinn, J., Lavin, M., Thornton, P., O’Donnell, J., Murphy, P., & Glavey, S. (2021). Validation of Risk-Adapted Venous Thromboembolism Prediction in Multiple Myeloma Patients. Journal of Clinical Medicine, 10(16), 3536. https://doi.org/10.3390/jcm10163536